about
Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virusEvolution of H3N2 influenza virus in a guinea pig modelGenetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France.Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.Influenza A H1N1 pandemic strain evolution--divergence and the potential for antigenic drift variants.A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza virusesProtection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.Molecular basis of antigenic drift in Influenza A/H3N2 strains (1968-2007) in the light of antigenantibody interactions.Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.Influenza mortality in the United States, 2009 pandemic: burden, timing and age distribution.Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete exampleProjection of seasonal influenza severity from sequence and serological dataSelective pressure to increase charge in immunodominant epitopes of the H3 hemagglutinin influenza protein.Antigenic variability in Neuraminidase protein of Influenza A/H3N2 vaccine strains (1968 - 2009).Ab and T cell epitopes of influenza A virus, knowledge and opportunitiesH3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic MapsEmergence of Hemagglutinin Mutations During the Course of Influenza Infection.Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.Isolation and genetic characterization of a novel 2.2.1.2a H5N1 virus from a vaccinated meat-turkeys flock in Egypt.Theoretical aspects of immunity.Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains.Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology.Glassy dynamics in the adaptive immune response prevents autoimmune disease.A genotype network reveals homoplastic cycles of convergent evolution in influenza A (H3N2) haemagglutinin.
P2860
Q21203781-E6F0193E-8F17-4B35-89B5-14E586FFC976Q28742283-0D781C5C-15A6-4862-B15F-51B11E8A840EQ30354246-42B59034-E04D-4D1E-9AD3-1F40B5B09710Q30356476-D9D92A3C-721C-4DED-9F9B-443C69FE428FQ30360996-32BB06BB-A1FD-42AC-8F43-6C7ECB006ABDQ30377217-DCEAA652-83C9-4300-BA5D-A8CF948AF2E8Q30397026-7490D67F-9CEB-4933-81D0-8179C1562A4AQ30404588-8227A9DB-B2B4-4EF8-A6D4-6CF72E74A71DQ30406634-C523F7F2-A61C-44C4-8776-84FCD7C928AAQ30431184-B2246078-A151-4112-982A-EA0365933AC1Q30857100-56F48B7B-63AC-4E68-9329-58633430F6EBQ33769997-6996AA18-9ECF-460A-91A1-DBC6E9BC05E8Q34551246-90728F20-60DA-4B00-A703-E56819CA8D1BQ35215548-66B8E6F3-F307-45E3-993A-BD8A58261665Q35575957-4D7A705E-E288-41C2-A71A-C850A28341F2Q36167993-7D84F155-2542-4D8B-83D1-C60A4BC6D88BQ36249828-C8742F89-735C-464E-A707-F2ACCBFED4B3Q36483319-A15E0EB2-1D86-421A-A34A-8C6FBCB005B3Q36557808-8F8588D9-89AE-40E3-B01A-0E419459B445Q37689937-D77F44BD-BE7F-44CA-AF52-CAB9609BDA18Q37995258-1CD00242-FB1D-4676-968C-E2396DD10354Q38856028-076499F9-CAE7-4BEC-ADF8-ED947B103833Q39025132-E4613BCE-3A0B-40F1-9F8A-1D27804C9B5DQ39794521-90F23A75-6E75-4331-9DD7-A6ABF4B9FA5FQ39923490-2D17689F-A5D1-4084-A6E7-73F8B7414887Q41831486-499A103B-C029-44A8-A517-A3451756C7E0Q45951581-FB8BEF62-30D5-4C21-B4B1-68E46E468B2EQ49767833-05D6D2F5-408D-43C9-A971-67CA3239F772Q51846145-7D086312-D47C-45CF-9144-9500C71EC0F8
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Epitope analysis for influenza vaccine design.
@ast
Epitope analysis for influenza vaccine design.
@en
type
label
Epitope analysis for influenza vaccine design.
@ast
Epitope analysis for influenza vaccine design.
@en
prefLabel
Epitope analysis for influenza vaccine design.
@ast
Epitope analysis for influenza vaccine design.
@en
P2860
P1433
P1476
Epitope analysis for influenza vaccine design
@en
P2093
Enrique T Muñoz
Michael W Deem
P2860
P304
P356
10.1016/J.VACCINE.2004.08.028
P407
P577
2005-01-01T00:00:00Z
P5875
P698
P818
q-bio/0408016